000 | 01445 a2200397 4500 | ||
---|---|---|---|
005 | 20250513120223.0 | ||
264 | 0 | _c19970827 | |
008 | 199708s 0 0 eng d | ||
022 | _a0968-0896 | ||
024 | 7 |
_a10.1016/s0968-0896(97)00012-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeitsch, H | |
245 | 0 | 0 |
_a3N-methylbiphenylsulfonylurea and -carbamate substituted imidazo[4,5-b]pyridines. Potent antagonists of the ANG II AT1 receptors. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry _cApr 1997 |
||
300 |
_a673-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAngiotensin II _xantagonists & inhibitors |
650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
650 | 0 | 4 | _aDecerebrate State |
650 | 0 | 4 |
_aDuodenum _xmetabolism |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aLethal Dose 50 |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aSulfonylurea Compounds _xadministration & dosage |
700 | 1 | _aBecker, R H | |
700 | 1 | _aKleemann, H W | |
700 | 1 | _aWagner, A | |
773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 5 _gno. 4 _gp. 673-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0968-0896(97)00012-6 _zAvailable from publisher's website |
999 |
_c9140112 _d9140112 |